ReviewBMC oral health2026
Hypomelanotic melanoma of the mandibular gingiva: a case report and literature review.
Review in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOral mucosal melanoma (OMM) is a rare and aggressive malignancy that exhibits distinct clinical and pathological characteristics compared to cutaneous melanomas. The hypomelanotic subtype of OMM is even rarer, with clinical signs and symptoms often being nonspecific, complicating the diagnostic process and contributing to a poor prognosis. Due to its rarity and the frequent delays in diagnosis, case reports are an invaluable source of information regarding this condition. A 78-year-old male presented with a painless mass on the left mandibular gingiva, which was initially misidentified as an inflammatory gingival lesion. After ineffective anti-inflammatory treatment, further investigation led to a confirmed diagnosis of hypomelanotic melanoma through histopathological and immunohistochemical examination.
conclusionEarly biopsy plays a critical role in establishing a definitive diagnosis for OMM. Histology combined with immunohistochemistry is the gold standard for diagnosing of hypomelanotic OMM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.